Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor

被引：4
|
作者：
Stocchi, F [1 ]
Vacca, L
Grassini, P
Battaglia, G
Onofrj, M
Valente, M
Ruggieri, S
机构：
[1] IRRCS Neuromed, Pozzilli, IS, Italy
[2] Univ Roma La Sapienza, Dept Neurosci, Rome, Italy
[3] Univ G DAnnunzio, Dept Neurooncol, Chieti, Italy
来源：
NEUROLOGICAL SCIENCES | 2003年 / 24卷 / 03期
关键词：
D O I：
10.1007/s10072-003-0138-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] Optimizing levodopa pharmacokinetics in Parkinson’s disease: the role of COMT inhibitor
    F. Stocchi
    L. Vacca
    P. Grassini
    G. Battaglia
    M. Onofrj
    M. Valente
    S. Ruggieri
    [J]. Neurological Sciences, 2003, 24 : 217 - 218
  • [2] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C. W.
    Kieburtz, K. D.
    Liang, G. S.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S7 - S7
  • [3] Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease
    Loewen, G.
    LeWitt, P.
    Olanow, C.
    Kieburtz, K.
    Liang, G.
    Jimenez, R.
    Olson, K.
    Roberts, E.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S62 - S62
  • [4] Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor
    Lee, Phil Hyu
    Kim, Han-Soo
    Lee, Ji E.
    Choi, Youjeong
    Hong, Jin Yong
    Nam, Hyo Suk
    Sohn, Young H.
    Kim, Hyun Ok
    [J]. PLOS ONE, 2011, 6 (06):
  • [5] Comparison of the pharmacokinetics between a COMT-inhibitor and levodopa
    Nagai, M.
    Kubo, M.
    Kyaw, W. T.
    Nishikawa, N.
    Nomoto, M.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S283 - S283
  • [6] A Phase 1 Study of Opicapone Pharmacokinetics and Its Effects on COMT Activity and Levodopa Pharmacokinetics in Patients with Stable Parkinson's Disease
    Loewen, Gordon
    LeWitt, Peter
    Olanow, C. Warren
    Kieburtz, Karl D.
    Liang, Grace S.
    Jimenez, Roland
    Olson, Kurt
    Roberts, Eiry
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S180 - S180
  • [7] Levodopa Therapy for Parkinson's Disease: Pharmacokinetics and Pharmacodynamics
    LeWitt, Peter A.
    [J]. MOVEMENT DISORDERS, 2015, 30 (01) : 64 - 72
  • [8] The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease
    Khor, Soo-Peang
    Hsu, Ann
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03): : 234 - 243
  • [9] First COMT inhibitor approved for Parkinson's disease
    不详
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (06) : 524 - +
  • [10] Opicapone (Ongentys) - A COMT Inhibitor for Parkinson's Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1615): : 3 - 5
12345